Portfolio Holdings Detail for ISIN IE00BGPP8L80

Stock Name / Fund	iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)
Issuer	Blackrock
Entity holding fund	iShares VI Public Limited Company
Entity Type
Entity LEI	549300VML6THE3JJOS76
ETF Ticker	WMVG(GBP) LSE
ETF Ticker	WMVG.L(GBP) LSE

Holdings detail for MRK

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45

IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06

Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation

(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21

Notable ETF Inflow Detected - VYM, JNJ, MRK, CME

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14

Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56

Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO

The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53

Guru Fundamental Report for MRK - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23

MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'

Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49

MRK Quantitative Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02

iShares MSCI ACWI ETF Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21

Dow Movers: WMT, MRK

In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42

MRK Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00

After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ

The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59

Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan

(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey

Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00

Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25

Peter Lynch Detailed Fundamental Analysis - MRK

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59

Top Analyst Reports for Merck, Palo Alto & Freeport

Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33

MRK April 2026 Options Begin Trading

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26

Stocks See Support As Bessent Calls for a Big Rate Cut

The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc) MRK holdings

Date	Number of MRK Shares Held	Base Market Value of MRK Shares	Local Market Value of MRK Shares	Change in MRK Shares Held	Change in MRK Base Value	Current Price per MRK Share Held	Previous Price per MRK Share Held
2025-11-27 (Thursday)	223,657	USD 23,401,232	USD 23,401,232	0	USD 0	USD 104.63	USD 104.63
2025-11-26 (Wednesday)	223,657	USD 23,401,232	USD 23,401,232	0	USD -230,367	USD 104.63	USD 105.66
2025-11-25 (Tuesday)	223,657	USD 23,631,599	USD 23,631,599	7,728	USD 1,952,327	USD 105.66	USD 100.4
2025-11-24 (Monday)	215,929	USD 21,679,272	USD 21,679,272	-96,975	USD -8,910,223	USD 100.4	USD 97.76
2025-11-21 (Friday)	312,904	USD 30,589,495	USD 30,589,495	0	USD 873,002	USD 97.76	USD 94.97
2025-11-20 (Thursday)	312,904	USD 29,716,493	USD 29,716,493	1,410	USD 108,988	USD 94.97	USD 95.05
2025-11-19 (Wednesday)	311,494	USD 29,607,505	USD 29,607,505	0	USD -429,861	USD 95.05	USD 96.43
2025-11-18 (Tuesday)	311,494	USD 30,037,366	USD 30,037,366	0	USD 1,112,033	USD 96.43	USD 92.86
2025-11-17 (Monday)	311,494	USD 28,925,333	USD 28,925,333	1,398	USD 111,213	USD 92.86	USD 92.92
2025-11-14 (Friday)	310,096	USD 28,814,120	USD 28,814,120	-2,796	USD -262,934	USD 92.92	USD 92.93
2025-11-13 (Thursday)	312,892	USD 29,077,054	USD 29,077,054	0	USD 463,081	USD 92.93	USD 91.45
2025-11-12 (Wednesday)	312,892	USD 28,613,973	USD 28,613,973	0	USD 156,446	USD 91.45	USD 90.95

Share Trades of MRK by Blackrock for IE00BGPP8L80

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-25	BUY	7,728	105.840	100.705	101.219	GBX 782,217	88.80
2025-11-24	SELL	-96,975	102.355	99.120	99.444	GBX -9,643,534	88.75 Loss of -1,037,364 on sale
2025-11-20	BUY	1,410	96.000	93.900	94.110	GBX 132,695	88.68
2025-11-17	BUY	1,398	94.740	92.675	92.882	GBX 129,848	88.60
2025-11-14	SELL	-2,796	95.075	91.490	91.849	GBX -256,809	88.58 Loss of -9,147 on sale
2025-11-04	SELL	-2,954	84.960	82.035	82.328	GBX -243,195	88.61 Profit of 18,548 on sale
2025-10-31	BUY	1,396	86.460	84.560	84.750	GBX 118,311	88.65
2025-10-28	SELL	-2,794	88.105	86.930	87.048	GBX -243,211	88.68 Profit of 4,552 on sale
2025-10-21	SELL	-2,792	87.670	86.230	86.374	GBX -241,156	88.70 Profit of 6,504 on sale
2025-10-14	SELL	-1,396	85.680	84.150	84.303	GBX -117,687	88.80 Profit of 6,281 on sale
2025-10-02	SELL	-5,707	91.000	88.220	88.498	GBX -505,058	88.80 Profit of 1,705 on sale
2025-10-01	BUY	3,434	90.750	85.190	85.746	GBX 294,452	88.79
2025-09-25	SELL	-1,384	79.875	77.600	77.827	GBX -107,713	88.98 Profit of 15,436 on sale
2025-09-09	SELL	-2,956			84.610*		89.13 Profit of 263,480 on sale
2025-07-28	SELL	-1,481	84.970	83.870	83.980	GBX -124,374	89.50 Profit of 8,169 on sale
2025-07-15	SELL	-5,524	84.360	81.300	81.606	GBX -450,792	89.72 Profit of 44,803 on sale
2025-07-11	SELL	-2,762	84.130	82.260	82.447	GBX -227,719	89.79 Profit of 20,284 on sale
2025-07-02	BUY	1,384	82.790	81.894	81.983	GBX 113,465	90.13
2025-06-30	SELL	-313	79.390	78.380	78.481	GBX -24,565	90.20 Profit of 3,668 on sale
2025-06-27	SELL	-4,350	79.540	78.140	78.280	GBX -340,518	90.27 Profit of 52,154 on sale
2025-06-26	BUY	1,373	80.250	78.370	78.558	GBX 107,860	90.34
2025-06-25	SELL	-1,373	80.120	79.160	79.256	GBX -108,818	90.41 Profit of 15,315 on sale
2025-06-23	SELL	-4,131	80.220	78.990	79.113	GBX -326,816	90.54 Profit of 47,216 on sale
2025-06-20	SELL	-1,377	79.920	78.600	78.732	GBX -108,414	90.62 Profit of 16,367 on sale
2025-06-16	SELL	-13,890	81.350	79.710	79.874	GBX -1,109,450	90.92 Profit of 153,394 on sale
2025-06-13	SELL	-1,374	82.440	81.450	81.549	GBX -112,048	90.98 Profit of 12,958 on sale
2025-06-12	SELL	-2,748	82.110	80.070	80.274	GBX -220,593	91.04 Profit of 29,590 on sale
2025-06-11	SELL	-6,870	81.680	79.980	80.150	GBX -550,631	91.12 Profit of 75,332 on sale
2025-06-09	SELL	-1,374	80.410	78.670	78.844	GBX -108,332	91.27 Profit of 17,067 on sale
2025-05-30	SELL	-1,371			76.840*		91.86 Profit of 125,944 on sale
2025-05-28	SELL	-1,369	77.725	75.590	75.803	GBX -103,775	92.09 Profit of 22,299 on sale
2025-05-21	SELL	-1,369	78.100	76.870	76.993	GBX -105,403	92.65 Profit of 21,432 on sale
2025-05-14	SELL	-18,460			73.470*		93.31 Profit of 1,722,554 on sale
2025-05-09	BUY	7,098			75.970*		93.69
2025-05-07	SELL	-5,472			79.120*		93.95 Profit of 514,079 on sale
2025-05-01	BUY	1,367	84.575	83.170	83.310	GBX 113,885	94.35
2025-04-29	SELL	-15,048	85.690	82.750	83.044	GBX -1,249,646	94.52 Profit of 172,636 on sale
2025-04-28	BUY	3,022	83.680	82.400	82.528	GBX 249,400	94.62
2025-04-25	BUY	1,359	83.280	78.060	78.582	GBX 106,793	94.72
2025-04-23	BUY	4,227	80.200	78.240	78.436	GBX 331,549	95.00
2025-04-22	BUY	12,258	79.035	77.660	77.798	GBX 953,642	95.14
2025-04-15	SELL	-4,086	79.960	77.720	77.944	GBX -318,479	95.80 Profit of 72,969 on sale
2025-04-14	BUY	6,950	80.010	78.360	78.525	GBX 545,749	95.96
2025-04-11	BUY	6,906	79.440	76.360	76.668	GBX 529,469	96.12
2025-04-09	SELL	-4,083	81.990	76.000	76.599	GBX -312,754	96.44 Profit of 81,025 on sale
2025-04-08	SELL	-5,444	83.270	77.540	78.113	GBX -425,247	96.62 Profit of 100,734 on sale
2025-04-07	SELL	-1,361	83.210	79.300	79.691	GBX -108,459	96.77 Profit of 23,246 on sale
2025-04-04	BUY	1,362	86.260	81.090	81.607	GBX 111,149	96.93
2025-04-01	BUY	5,452			87.120*		97.13
2025-03-27	SELL	-2,730			87.600*		97.40 Profit of 265,894 on sale
2025-03-21	SELL	-1,364			93.110*		97.71 Profit of 133,277 on sale
2025-03-14	BUY	4,098			94.570*		97.90
2025-03-13	BUY	1,365			94.710*		97.93
2025-03-12	BUY	2,732			93.350*		97.99
2025-03-11	BUY	2,732			94.730*		98.03
2025-03-10	SELL	-1,365			95.230*		98.06 Profit of 133,856 on sale
2025-03-07	BUY	22,831			94.650*		98.11
2025-03-05	BUY	6,830			93.190*		98.17
2025-03-04	BUY	2,732			92.560*		98.24
2025-03-03	BUY	5,464	92.790	91.810	91.908	GBX 502,185	98.31
2025-02-28	BUY	3,248	92.350	90.710	90.874	GBX 295,159	98.39
2025-02-27	BUY	1,355	90.970	89.250	89.422	GBX 121,167	98.49
2025-02-26	BUY	10,824	91.370	88.860	89.111	GBX 964,537	98.61
2025-02-25	BUY	2,706	93.060	90.440	90.702	GBX 245,440	98.71
2025-02-20	BUY	4,059	87.700	85.900	86.080	GBX 349,399	99.11
2025-02-05	BUY	1,351	90.740	87.995	88.270	GBX 119,252	101.60
2025-02-04	BUY	1,352	91.230	87.330	87.720	GBX 118,597	101.79
2025-01-31	SELL	-1,352	100.060	98.580	98.728	GBX -133,480	101.88 Profit of 4,258 on sale
2025-01-30	BUY	1,352	99.410	98.230	98.348	GBX 132,967	101.93
2025-01-29	SELL	-1,352	99.150	97.390	97.566	GBX -131,909	102.00 Profit of 5,993 on sale
2025-01-28	BUY	2,704	98.880	96.590	96.819	GBX 261,799	102.08
2025-01-27	SELL	-1,352	98.620	95.990	96.253	GBX -130,134	102.16 Profit of 7,992 on sale
2024-12-10	SELL	-1,355	103.770	100.750	101.052	GBX -136,925	102.44 Profit of 1,875 on sale
2024-12-03	SELL	-2,710	102.450	100.620	100.803	GBX -273,176	102.40 Profit of 4,334 on sale
2024-11-29	SELL	-1,353	103.040	101.530	101.681	GBX -137,574	102.46 Profit of 1,058 on sale
2024-11-25	BUY	21,841	101.740	99.510	99.733	GBX 2,178,268	102.55
2024-11-25	BUY	21,841	101.740	99.510	99.733	GBX 2,178,268	102.55
2024-11-22	SELL	-3,813	101.790	98.930	99.216	GBX -378,311	102.64 Profit of 13,063 on sale
2024-11-05	SELL	-10,168	101.730	100.520	100.641	GBX -1,023,318	104.28 Profit of 36,972 on sale
2024-11-05	SELL	-10,168	101.730	100.520	100.641	GBX -1,023,318	104.28 Profit of 36,972 on sale
2024-10-31	SELL	-2,563	103.230	98.600	99.063	GBX -253,898	105.18 Profit of 15,674 on sale
2024-10-31	SELL	-2,563	103.230	98.600	99.063	GBX -253,898	105.18 Profit of 15,674 on sale
2024-10-29	BUY	1,277	105.110	103.700	103.841	GBX 132,605	105.51
2024-10-29	BUY	1,277	105.110	103.700	103.841	GBX 132,605	105.51
2024-10-24	BUY	1,277	106.620	105.260	105.396	GBX 134,591	106.48
2024-10-24	BUY	1,277	106.620	105.260	105.396	GBX 134,591	106.48

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.